Accelerate Your Drug Development with QPS Real-World Evidence (RWE) Services
Harnessing Real-World Data for Innovative Insights
At QPS, we leverage Real-World Evidence (RWE) to transform drug development and enhance patient outcomes. Our comprehensive RWE services utilize routinely collected patient health data, known as Real-World Data (RWD), to deliver insights beyond traditional clinical trials. This data-driven approach helps fill evidence gaps, supports more inclusive research, reduces reliance on animal models, and accelerates access to innovative therapies.
Why QPS for Real-World Studies?
Innovation
QPS has partnered with Ryght AI as our exclusive AI partner.
Innovation
Utilizing AI to optimize and automate trials on a global scale is the next big opportunity to scale drug development. Ryght Ai's cutting-edge Ryght AI’s cutting-edge AI technology, coupled with QPS’s experience and global presence in clinical trials is set to address key challenges in the clinical research sector.
Data Resources
We integrate a variety of global data sources into a centralized data lake environment.
Data Resources
We integrate electronic health records (EHRs), pathology results, registries, and genomic data into a centralized data lake environment enhanced by AI and machine learning for deeper clinical insights. From early-stage research to post-marketing surveillance and label expansions, QPS assembles the right data, analytical tools, and expertise to meet evolving project demands effectively.
Global Operations
Truly global clinical operations departments work together seamlessly.
Global Operations
Our global infrastructure includes clinical research units and over 700 partner sites in the US, Europe, Asia, Australia, and India, allowing us to provide comprehensive support at every stage of the product lifecycle.
Learn more
Therapeutic Experts
QPS has 30 years of experience supporting drug development programs across all therapeutic areas.
Therapeutic Experts
Whether it’s oncology, CNS disorders, or rare diseases, our datasets are designed to support the unique needs of each therapeutic area. Our therapeutic coverage allows for data-driven strategies across a diverse range of indications, including obesity, oncology, CNS disorders, dermatology, vaccines, and rare diseases.
Learn More
Integrative Specialty Data
Our team of data specialists is dedicated to advancing drug development using the latest technology.
Integrative Specialty Data
Our client-first model is underpinned by a multidisciplinary team of physicians, investigators, data scientists, biostatisticians, medical writers, and pharmacovigilance experts, all working seamlessly under one umbrella to deliver comprehensive project support. This targeted approach allows researchers to focus on specific questions and hypotheses, leading to more meaningful and actionable insights.
Learn More
Powerful Persuasive Insights
Discover data sets designed to uncover the insights you need to accelerate your drug development program.
Powerful Persuasive Insights
We integrate electronic health records (EHRs), pathology results, registries, and genomic data into a centralized data lake environment enhanced by AI and machine learning for deeper clinical insights. We develop customized datasets tailored to specific therapeutic areas, enabling more targeted analysis and improved decision-making. Our datasets are meticulously curated to include relevant patient information, clinical outcomes, and treatment histories.
Learn More
Advanced Algorithms
The tools you need to extract meaning full insights and complete submissions to relevant regulatory agencies.
Advanced Algorithms
Our analytical tools and methodologies are designed to extract meaningful insights from complex datasets, providing clear and concise reports that meet regulatory requirements. We offer end-to-end support for data analysis, from initial data processing to final report generation, ensuring that our clients have the information they need to make informed decisions and achieve regulatory success.
World Class Regulatory Expertise
Comprehensive data management, coupled with a deep understanding of Artificial Intelligence delivers unmatched insights.
World Class Expertise
We deliver structured data analysis, comprehensive reporting, and regulatory-ready documentation to accelerate submissions and approvals. Longitudinal tracking ensures that we capture the full spectrum of patient experiences over time, offering insights into long-term efficacy and safety of therapies.
GDPR and HIPAA-Compliant
QPS maintains strict adherence to regulatory rules and regulations, including HIPPA, CLIA and GDPR.
GDPR and HIPAA-Compliant
We collect data in real time and retrospectively, while maintaining strict adherence to global regulatory standards, including 21 CFR part 11 and GDPR, to ensure data privacy, security, and compliance. Our data collection capabilities allow for continuous monitoring of patient health and treatment outcomes, providing up-to-date information for timely decision-making.
Learn More
Specialized Product Areas
At QPS, we combine therapeutic expertise with experience in optimizing and executing RWE studies for specialized product areas and patient populations to uncover your product’s impact on patient outcomes.
We have experience across more than 15 major therapeutic areas including:
- Cardiovascular
- Central Nervous System
- Dermatology
- Endocrinology/Diabetes
- Gastroenterology
- Immunology
- Infectious Disease
- Obesity
- Oncology
- Ophthalmology
- Pulmonology
- Rare Diseases
- Rheumatology
- Vaccines
- Women’s Health
Types of QPS Data Available
Data access and management processes have evolved given the fast pace evolution of big data transformation technology, Artificial Intelligence, and increased importance of Real-World Data. QPS benefits from strong expertise in managing proprietary data sets and has invested in Artificial Intelligence platforms to collect or enable access to data to be cleaned, curated, bridged, harmonized, and/or linked. The additional ability to de-identify data for compliant use enables us to generate evidence that leads to insights to support your next Real World Evidence project.
Why Choose QPS?
- Global Reach and Infrastructure: Our global infrastructure includes clinical research units and over 700 partner sites across the US, Europe, Asia, Australia, and India, allowing us to provide comprehensive support at every stage of the product lifecycle.
- Expertise Across Therapeutic Areas: Our therapeutic agnosticism allows for data-driven strategies across a diverse range of indications, including oncology, CNS disorders, dermatology, vaccines, and rare diseases.
- Multidisciplinary Team: Our client-first model is underpinned by a multidisciplinary team of data scientists, biostatisticians, medical writers, and pharmacovigilance experts, all working seamlessly under one umbrella to deliver comprehensive project support.
- Lifecycle Support: From early-stage research to post-marketing surveillance and label expansions, QPS assembles the right data, analytical tools, and expertise to meet evolving project demands effectively.
Contact Us
Ready to accelerate your drug development with QPS RWE services?
Contact us today to discuss how we can help you apply RWD/RWE integration for more efficient product development.
Visit: http://www.qps.com/
Set Up a Meeting: http://www.qps.com/contact
Email: info@qps.com
